| ◆英語タイトル：Global Apheresis Market Size study & Forecast, by Product (Devices, Disposable and Reagents, Software), by Method (Centrifugation, Membrane Separation, Selective Adsorption), by Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), by Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), RBCs (Erythropheresis)), by End-User (Blood Centers, Hospitals, Other End-Users) and Regional Analysis, 2022-2029
|
 | ◆商品コード：BZW23FE0082
◆発行会社（リサーチ会社）：Bizwit Research & Consulting
◆発行日：2023年2月8日
◆ページ数：約200
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆産業分野：医療機器
|
◆販売価格オプション
（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
Bizwit Research社は、2021年に約24億ドルであった世界のアフェレシス市場規模は、2022年から2029年の間にCAGR 8.3％増加すると予想しています。本書は、アフェレシスの世界市場について調査・分析を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（機器、消耗品・試薬、ソフトウェア）分析、方法別（遠心分離、膜分離、選択的吸着）分析、処置別（ドナー/自動アフェレシス、治療アフェレシス）分析、成分別（血漿（プラズマフェレシス）、血小板（血小板フェレシス）、白血球（白血球フェレシス）、リンパ球（リンパフェレシス）、赤血球（赤血球フェレシス））分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの内容をまとめています。また、本書で記載されている企業情報には、Terumo BCT, Inc. (US)、Fresenius SE & Co. KGaA (Germany)、Haemonetics Corporation (US)、Asahi Kasei Medical Co. Ltd. (Japan)、B. Braun Melsungen AG (Germany)などが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界アフェレシス市場規模：製品別
- アフェレシス機器の市場規模
- アフェレシス消耗品・試薬の市場規模
- アフェレシスソフトウェアの市場規模
・世界アフェレシス市場規模：方法別
- 遠心分離法における市場規模
- 膜分離法における市場規模
- 選択的吸着法における市場規模
・世界アフェレシス市場規模：処置別
- ドナー/自動アフェレシスにおける市場規模
- 治療アフェレシスにおける市場規模
・世界アフェレシス市場規模：成分別
- 血漿（プラズマフェレシス）における市場規模
- 血小板（血小板フェレシス）における市場規模
- 白血球（白血球フェレシス）における市場規模
- リンパ球（リンパフェレシス）における市場規模
- 赤血球（赤血球フェレシス）における市場規模
・世界のアフェレシス市場規模：地域別
- 北米のアフェレシス市場
- ヨーロッパのアフェレシス市場
- アジア太平洋のアフェレシス市場
- 中南米のアフェレシス市場
- その他地域のアフェレシス市場
・競争分析
・調査プロセス |
Global Apheresis Market is valued at approximately USD 2.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Apheresis refers to a medical technology in which the blood of a person is passed through an apheresis device that filters out one constituent and returns the remainder to circulation. Moreover, apheresis is used in the treatment of a wide range of conditions including sickle cell disease, leukemia, myasthenia gravis, breast and Colon cancer, Multiple myeloma, and other blood disorders. The rising prevalence of chronic diseases and increasing government initiatives towards blood donation as well as growing demand for blood components are key factors accelerating the market growth.
The increasing prevalence of chronic diseases is contributing to the growth of the Global Apheresis Market. For instance, as per Leukemia & Lymphoma Society estimates- as of 2021, an estimated 397,501 individuals are living with leukemia in the United States. In addition, during 2021, it is estimated that around 61090 individuals in the US would be diagnosed with leukemia and an estimated 21,680 US individuals are anticipated to die from lymphoma in 2021. Also, favorable reimbursement policies from government authorities and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Apheresis devices stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Apheresis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players and increasing incidences of blood disorders in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising healthcare infrastructure, penetration of leading medical equipment manufacturers in the region and favorable government initiatives to promote blood donation in the region.
Major market players included in this report are:
Terumo BCT, Inc. (US)
Fresenius SE & Co. KGaA (Germany)
Haemonetics Corporation (US)
Asahi Kasei Medical Co. Ltd. (Japan)
B. Braun Melsungen AG (Germany)
Baxter International Inc. (US)
Cerus Corporation (US)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Nikkiso Co., Ltd. (Japan)
Recent Developments in the Market:
In June 2019, Tokyo, Japan based Toray Medical Co. Ltd. announced the launch of the TORAMYXIN device inEurope.
In June 2022, The UK’s NHS England chosen Terumo Blood and Cell Technologies’s Spectra Optia® Apheresis System through the NHS MedTech Funding Mandate (MTFM) for the automated red blood cell exchange (RBCX) procedure.
Global Apheresis Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Method, Procedure, Component, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Devices
Disposable and Reagents
Software
By Method
Centrifugation
Membrane Separation
Selective Adsorption
By Procedure
Donor/Automated Apheresis
Therapeutic Apheresis
By Component
Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or leukopheresis)
Lymphocytes (Lymphopheresis or lymphapheresis)
RBCs (Erythropheresis)
By End-User
Blood Centers
Hospitals
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Apheresis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Apheresis Market, by Product, 2019-2029 (USD Billion)
1.2.3. Apheresis Market, by Method, 2019-2029 (USD Billion)
1.2.4. Apheresis Market, by Procedure, 2019-2029 (USD Billion)
1.2.5. Apheresis Market, by Component, 2019-2029 (USD Billion)
1.2.6. Apheresis Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Apheresis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Apheresis Market Dynamics
3.1. Apheresis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of Chronic Diseases
3.1.1.2. Increasing government initiatives towards blood donation
3.1.1.3. Growing demand for blood components
3.1.2. Market Challenges
3.1.2.1. High Cost of Apheresis devices
3.1.3. Market Opportunities
3.1.3.1. Favourable reimbursement policies from government authorities
3.1.3.2. Rising healthcare infrastructure in developing regions
Chapter 4. Global Apheresis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Apheresis Market, by Product
6.1. Market Snapshot
6.2. Global Apheresis Market by Product, Performance – Potential Analysis
6.3. Global Apheresis Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Apheresis Market, Sub Segment Analysis
6.4.1. Devices
6.4.2. Disposable and Reagents
6.4.3. Software
Chapter 7. Global Apheresis Market, by Method
7.1. Market Snapshot
7.2. Global Apheresis Market by Method, Performance – Potential Analysis
7.3. Global Apheresis Market Estimates & Forecasts by Method 2019-2029 (USD Billion)
7.4. Apheresis Market, Sub Segment Analysis
7.4.1. Centrifugation
7.4.2. Membrane Separation
7.4.3. Selective Adsorption
Chapter 8. Global Apheresis Market, by Procedure
8.1. Market Snapshot
8.2. Global Apheresis Market by Procedure, Performance – Potential Analysis
8.3. Global Apheresis Market Estimates & Forecasts by Procedure 2019-2029 (USD Billion)
8.4. Apheresis Market, Sub Segment Analysis
8.4.1. Donor/Automated Apheresis
8.4.2. Therapeutic Apheresis
Chapter 9. Global Apheresis Market, by Component
9.1. Market Snapshot
9.2. Global Apheresis Market by Component, Performance – Potential Analysis
9.3. Global Apheresis Market Estimates & Forecasts by Component 2019-2029 (USD Billion)
9.4. Apheresis Market, Sub Segment Analysis
9.4.1. Plasma (Plasmapheresis)
9.4.2. Platelets (Plateletpheresis)
9.4.3. Leukocytes (Leukapheresis or leukopheresis)
9.4.4. Lymphocytes (Lymphopheresis or lymphapheresis)
9.4.5. RBCs (Erythropheresis)
Chapter 10. Global Apheresis Market, by End-User
10.1. Market Snapshot
10.2. Global Apheresis Market by End-User, Performance – Potential Analysis
10.3. Global Apheresis Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
10.4. Apheresis Market, Sub Segment Analysis
10.4.1. Blood Centers
10.4.2. Hospitals
10.4.3. Other End-Users
Chapter 11. Global Apheresis Market, Regional Analysis
11.1. Apheresis Market, Regional Market Snapshot
11.2. North America Apheresis Market
11.2.1. U.S. Apheresis Market
11.2.1.1. Product breakdown estimates & forecasts, 2019-2029
11.2.1.2. Method breakdown estimates & forecasts, 2019-2029
11.2.1.3. Procedure breakdown estimates & forecasts, 2019-2029
11.2.1.4. Component breakdown estimates & forecasts, 2019-2029
11.2.1.5. End-User breakdown estimates & forecasts, 2019-2029
11.2.2. Canada Apheresis Market
11.3. Europe Apheresis Market Snapshot
11.3.1. U.K. Apheresis Market
11.3.2. Germany Apheresis Market
11.3.3. France Apheresis Market
11.3.4. Spain Apheresis Market
11.3.5. Italy Apheresis Market
11.3.6. Rest of Europe Apheresis Market
11.4. Asia-Pacific Apheresis Market Snapshot
11.4.1. China Apheresis Market
11.4.2. India Apheresis Market
11.4.3. Japan Apheresis Market
11.4.4. Australia Apheresis Market
11.4.5. South Korea Apheresis Market
11.4.6. Rest of Asia Pacific Apheresis Market
11.5. Latin America Apheresis Market Snapshot
11.5.1. Brazil Apheresis Market
11.5.2. Mexico Apheresis Market
11.5.3. Rest of Latin America Apheresis Market
11.6. Rest of The World Apheresis Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Terumo BCT, Inc. (US)
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. Fresenius SE & Co. KGaA (Germany)
12.2.3. Haemonetics Corporation (US)
12.2.4. Asahi Kasei Medical Co. Ltd. (Japan)
12.2.5. B. Braun Melsungen AG (Germany)
12.2.6. Baxter International Inc. (US)
12.2.7. Cerus Corporation (US)
12.2.8. Kaneka Corporation (Japan)
12.2.9. Kawasumi Laboratories, Inc. (Japan)
12.2.10. Nikkiso Co., Ltd. (Japan)
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption
❖ 免責事項 ❖http://www.globalresearch.jp/disclaimer